Nantahala Capital Management LLC purchased a new stake in Owens & Minor, Inc. (NYSE:OMI - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 200,000 shares of the company's stock, valued at approximately $1,806,000. Nantahala Capital Management LLC owned 0.26% of Owens & Minor as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Vanguard Group Inc. boosted its holdings in shares of Owens & Minor by 2.7% in the first quarter. Vanguard Group Inc. now owns 9,156,759 shares of the company's stock valued at $82,686,000 after buying an additional 241,003 shares during the period. Coliseum Capital Management LLC boosted its holdings in Owens & Minor by 31.3% during the fourth quarter. Coliseum Capital Management LLC now owns 4,785,964 shares of the company's stock worth $62,553,000 after purchasing an additional 1,141,483 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in Owens & Minor by 19.4% during the first quarter. Charles Schwab Investment Management Inc. now owns 2,752,960 shares of the company's stock worth $24,859,000 after purchasing an additional 447,917 shares during the last quarter. Invesco Ltd. boosted its holdings in Owens & Minor by 19.9% during the first quarter. Invesco Ltd. now owns 1,716,895 shares of the company's stock worth $15,504,000 after purchasing an additional 285,060 shares during the last quarter. Finally, Northern Trust Corp boosted its holdings in Owens & Minor by 13.7% during the fourth quarter. Northern Trust Corp now owns 968,101 shares of the company's stock worth $12,653,000 after purchasing an additional 116,754 shares during the last quarter. Institutional investors and hedge funds own 98.04% of the company's stock.
Insider Buying and Selling at Owens & Minor
In related news, major shareholder Coliseum Capital Management, L purchased 492,852 shares of Owens & Minor stock in a transaction dated Thursday, August 14th. The shares were bought at an average cost of $5.31 per share, for a total transaction of $2,617,044.12. Following the purchase, the insider owned 13,100,807 shares in the company, valued at approximately $69,565,285.17. This trade represents a 3.91% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In the last 90 days, insiders have purchased 1,537,852 shares of company stock valued at $8,099,544. Company insiders own 3.69% of the company's stock.
Owens & Minor Price Performance
Owens & Minor stock traded up $0.22 during trading hours on Friday, reaching $5.62. 1,564,972 shares of the stock were exchanged, compared to its average volume of 2,132,664. The company has a market cap of $433.70 million, a P/E ratio of -0.36 and a beta of 1.03. The company has a current ratio of 0.86, a quick ratio of 0.83 and a debt-to-equity ratio of 3.32. Owens & Minor, Inc. has a twelve month low of $4.56 and a twelve month high of $16.47. The stock has a 50 day moving average of $6.84 and a two-hundred day moving average of $7.44.
Owens & Minor (NYSE:OMI - Get Free Report) last posted its quarterly earnings results on Monday, August 11th. The company reported $0.26 earnings per share for the quarter, missing analysts' consensus estimates of $0.27 by ($0.01). Owens & Minor had a negative net margin of 13.78% and a positive return on equity of 26.59%. The company had revenue of $681.90 million during the quarter, compared to analyst estimates of $2.73 billion. During the same quarter in the previous year, the business posted $0.36 earnings per share. The company's revenue for the quarter was up 3.3% on a year-over-year basis. Owens & Minor has set its FY 2025 guidance at 1.020-1.070 EPS. Equities analysts expect that Owens & Minor, Inc. will post 1.51 EPS for the current fiscal year.
Analyst Ratings Changes
OMI has been the subject of several recent research reports. UBS Group set a $7.00 target price on shares of Owens & Minor in a report on Wednesday, August 13th. JPMorgan Chase & Co. dropped their price objective on shares of Owens & Minor from $7.00 to $6.00 and set an "underweight" rating on the stock in a research report on Wednesday, August 27th. Robert W. Baird dropped their price objective on shares of Owens & Minor from $10.00 to $7.00 and set an "outperform" rating on the stock in a research report on Tuesday, August 12th. Citigroup reaffirmed a "buy" rating and set a $7.00 price target (down from $11.00) on shares of Owens & Minor in a research report on Tuesday, August 12th. Finally, Baird R W upgraded shares of Owens & Minor from a "hold" rating to a "strong-buy" rating in a research note on Friday, August 8th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, one has given a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $7.63.
View Our Latest Analysis on Owens & Minor
About Owens & Minor
(
Free Report)
Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.
Further Reading

Before you consider Owens & Minor, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Owens & Minor wasn't on the list.
While Owens & Minor currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.